| Clear Cell Renal Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 58show all (up to 200) |
|---|
| → investigated in trials for | Nivolumabmonoclonal antibody 33 trials (20 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Renal Cell Carcinoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 19 trials (16 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Renal Cell Carcinoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 19 trials (11 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Renal Cell Carcinoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 18 trials (15 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Renal Cell Carcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 17 trials (9 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Renal Cell Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall_molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Renal Cell Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Renal Cell Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belzutifansmall_molecule 8 trials (7 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Renal Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Renal Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Renal Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Renal Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Renal Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Renal Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall_molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Renal Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Renal Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |